Mereo BioPharma Group plc
MREO
$0.24
-$0.01-4.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 52.07% | 47.86% | -4.33% | 53.17% | -19.25% |
| Total Depreciation and Amortization | 0.34% | 12.96% | 116.06% | -103.90% | 15.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.90% | -101.23% | 137.75% | -107.86% | 208.42% |
| Change in Net Operating Assets | -18.27% | 520.43% | -362.08% | 128.96% | -150.75% |
| Cash from Operations | 21.02% | 48.23% | 18.45% | 2.79% | 3.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00% | -- | -- | -100.00% |
| Cash from Investing | -- | 6.25% | -- | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 100.00% | 38.81% |
| Cash from Financing | -- | -- | 197.50% | 100.00% | -100.29% |
| Foreign Exchange rate Adjustments | -104.34% | -117.29% | 95.00% | -134.72% | 1,433.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.98% | 34.84% | 28.12% | -7.50% | -116.40% |